VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 å resolution and mutational analysis of the interface-Reference-Cited by-同舟云学术

VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 å resolution and mutational analysis of the interface

Published:1998-09 Issue:9 Volume:6 Page:1153-1167
ISSN:0969-2126
Container-title:Structure
language:en
Short-container-title:Structure

Author:

Muller Yves A,Chen Yvonne,Christinger Hans W,Li Bing,Cunningham Brian C,Lowman Henry B,de Vos Abraham M

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference57 articles.

1. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis;Dvorak;Am. J. Pathol,1995

2. The role of vascular endothelial growth factor in pathological angiogenesis;Ferrara;Breast Cancer Res. Treat,1995

3. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat. Med,1995

4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele;Carmeliet;Nature,1996

5. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene;Ferrara;Nature,1996

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicle-bound VEGF in oral squamous cell carcinoma and its role in resistance to Bevacizumab Therapy;Cancer Cell International;2024-08-23

2. Targeting the interaction of pleiotrophin and VEGFA165 with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis;European Journal of Pharmacology;2024-08

3. LC–MS Characterization and Stability Assessment Elucidate Correlation Between Charge Variant Composition and Degradation of Monoclonal Antibody Therapeutics;The AAPS Journal;2024-04-03

4. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation;Acta Neuropathologica;2024-01-24

5. Current Status of Angiogenesis Inhibitors as Second-Line Treatment for Unresectable Colorectal Cancer;Cancers;2023-09-14